<--- Back to Details
First PageDocument Content
Gilead Sciences / Chemistry / Fixed dose combination / Pharmacology / Organic chemistry / Bristol-Myers Squibb / Non-nucleoside reverse transcriptase inhibitors / Organofluorides / Tenofovir disoproxil / Efavirenz/emtricitabine/tenofovir / Tenofovir/emtricitabine / Fixed-dose combination
Date: 2016-03-03 11:54:31
Gilead Sciences
Chemistry
Fixed dose combination
Pharmacology
Organic chemistry
Bristol-Myers Squibb
Non-nucleoside reverse transcriptase inhibitors
Organofluorides
Tenofovir disoproxil
Efavirenz/emtricitabine/tenofovir
Tenofovir/emtricitabine
Fixed-dose combination

BMS_Gilead_Logo_FINAL.eps

Add to Reading List

Source URL: packageinserts.bms.com

Download Document from Source Website

File Size: 579,03 KB

Share Document on Facebook

Similar Documents

PDF Document

DocID: 1xvUb - View Document

PDF Document

DocID: 1xc8R - View Document

Institute of Pharmacology www.pki.unibe.ch Introduction Prof. Dr. Dr. Stephan von Gunten MD PhD MME

DocID: 1vqsj - View Document

Jansone et al.: Intrinsic Activity, 2017; 5 (Suppl.2):A1.6 doi:IA.5.S2-A1.6 published online: 16 October 2017 2nd International Conference in Pharmacology: From Cellular Processes to Drug Targets Rīga, Latvia

DocID: 1vlJU - View Document

Human cells Notable for research in: -Medecine: Diseases and cancers -Cell Biology -Pharmacology

DocID: 1vk1K - View Document